Interestingly, IL-22 stimulation of BCC and SCC lines resulted in the activation of Erk1/2, STAT3 and Akt molecules, suggesting that these pathways may be responsible for the proliferative effects mediated by IL-22 observed both in vivo and in vitro [10]. The gene discussed is STAT3; the disease is skin basal cell carcinoma.